Bristol-Myers Squibb has won FDA approval for the first LAG-3 inhibitor drug ahead of its rivals in cancer immunotherapy, including Merck & Co. The US regulator cleared BMS' LAG-3 drug relatlimab as a ...
Bristol-Myers Squibb has claimed its second FDA approval in the space of a few days for its immuno-oncology combination of Opdivo and Yervoy, this time in newly diagnosed liver cancer. PD-1 inhibitor ...
India Today on MSN
Why govt got quick-commerce platforms to exit 10-minute delivery race
Amidst pressure from RSS affiliates, the government's move is a recalibration of India's digital commerce ecosystem to ...
Welcome to Bollywood Hungama's "New Latest Movies" page, your passport to the enchanting world of cinema. Whether you're an avid Bollywood aficionado or a dedicated follower of Hollywood's cinematic ...
Welcome to Bollywood Hungama's "New Latest Movies" page, your passport to the enchanting world of cinema. Whether you're an avid Bollywood aficionado or a dedicated follower of Hollywood's cinematic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results